share_log

Morgan Stanley Maintains Overweight on Pharvaris, Lowers Price Target to $34

Moomoo 24/7 ·  Apr 15 12:45

Morgan Stanley analyst Matthew Harrison maintains Pharvaris (NASDAQ:PHVS) with a Overweight and lowers the price target from $35 to $34.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment